Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to January 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $1.6B |
| Sales growthchange from the year before | +29.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 76.7% |
| Operating marginshare of sales left after running the business | -3.2% |
| Net marginshare of sales kept as profit | -0.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | 12.8% |
| Return on invested capitalprofit made on each $100 put into the business | -2.9% |
| Return on equityprofit vs. shareholders' accounting value | -0.6% |
| Change in share countnegative = the company is buying back its shares | +3.1% |
5 insiders sold $20.5M (all under pre-arranged plans) on the open market.
| Phillips DominicSee Remarks | Sold (plan)Aug 3 | 29,618 shat $37.62 · $1.1M |
| Eltoukhy AdamSee Remarks | Sold (plan)Jul 28 | 3,653 shat $37.00 · $135K |
| Eltoukhy AdamSee Remarks | Sold (plan)Jul 27 | 3,653 shat $34.95 · $128K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy